Skip to main content

BNP PARIBAS ARBITRAGE, SA

Position in BHVN — Biohaven Ltd.

CIK 1166588 NEW YORK, NY

Position in BHVN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$18,219,399
+$5,154,300 QoQ
Shares Held
1,224,422
-20.7% QoQ
Ownership
0.811%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#26
of 294 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in BHVN Over Time

Shares Held

Position Value (USD)

Derivatives in BHVN

reported options exposure · as of Mar 31, 2025
CallValue
$2,163
CallShares
90
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BNP PARIBAS ARBITRAGE, SA holds $3,275,701,265 across 414 Biotechnology names. BHVN ranks #47 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in BHVN

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $18,219,399 1,224,422
2026-03-31 $13,065,099 1,544,338
2025-12-31 $23,639,182 2,093,816
2025-09-30 $12,661,895 843,564
2025-06-30 $8,869,856 628,622
2025-03-31 $2,163 90
2025-03-31 $213,499 8,881
2024-12-31 $1,559,810 41,762